wall street stock marion lab mkc marion laboratory stock rise sharply company bullish earn scenario meet pharmaceutical analyst monday trader analyst company expect earn fiscal june rise pct ago pronouncement encourage analyst david crossen sanford bernstein raise earn estimate company dollar share compare previous estimate dollar share company earn share marion stock gain meet pharmaceutical analyst marion president fred lyon jr wall street eanrings estimate dollar share fiscal expect aggressive range lyon strong performance half result fourth quarter introduction mg mg cardizem tablet analyst crossen cardizem treat angina expect approve treatment hypertension crossen marion company growth cardizem impact bottom line raise fiscal earn estimate dollar share previous estimate dollar share company broad product pipeline industry concern innovative company business crossen expect marion growth rate pct 
